SCHEMBL4192565

SCHEMBL4192565

C[C@@H](CC1CCCC1)NCc1ccccc1NS(=O)(=O)c1ccc(F)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
PKM P14618 1/20 0.47
ALDH1A1 P00352 4/20 0.43
RECQL P46063 1/20 0.42
LMNA P02545 6/20 0.42
POLB P06746 3/20 0.42
TSHR P16473 1/20 0.41
GLO1 Q04760 1/20 0.40
KMT2A Q03164 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
ACLY P53396 1/20 0.39
STAT3 P40763 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MOGAT2 Q3SYC2 1/20 0.38
MAPT P10636 3/20 0.37
TP53 P04637 2/20 0.37
THRB P10828 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MEN1 O00255 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4193899 0.88 PKM (0.53) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL12050344 0.85 KDM4E (0.55) KDM4EPKMALDH1A1LMNAPOLB
Cyclopentane SCHEMBL4192569 0.85 KDM4E (0.48) KDM4EPKMALDH1A1RECQLLMNA
SCHEMBL4199567 0.85 KDM4E (0.52) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4194586 0.85 KDM4E (0.52) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4193413 0.84 ACLY (0.48) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4203965 0.84 KDM4E (0.39) KDM4EPKMALDH1A1RECQLLMNA
SCHEMBL4194889 0.84 ACLY (0.47) KDM4EPKMALDH1A1LMNAPOLB
SCHEMBL4184025 0.84 KDM4E (0.39) KDM4EPKMALDH1A1LMNAACLY
SCHEMBL14343935 0.84 KDM4E (0.41) KDM4EPKMALDH1A1RECQLLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 KDM4E 3328/4885PKM 1855/4885ALDH1A1 2744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.